Baker Bros. Advisors’s Sana Biotechnology SANA Stock Holding History

Baker Bros. Advisors’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08M	Hold	310,483	–	–	0.01%	81
2026 Q1	$894K	Hold	310,483	–	–	0.01%	81
2025 Q4	$1.26M	Sell	310,483 -1,720,466	-85%	-$7.7M	0.01%	80
2025 Q3	$7.21M	Hold	2,030,949	–	–	0.05%	67
2025 Q2	$5.54M	Hold	2,030,949	–	–	0.05%	66
2025 Q1	$3.41M	Sell	2,030,949 -350,000	-15%	-$978K	0.04%	67
2024 Q4	$3.88M	Hold	2,380,949	–	–	0.04%	76
2024 Q3	$9.9M	Hold	2,380,949	–	–	0.1%	53
2024 Q2	$13M	Hold	2,380,949	–	–	0.17%	44
2024 Q1	$23.8M	Buy	2,380,949 +380,949	+19%	+$2.85M	0.3%	37
2023 Q4	$8.16M	Hold	2,000,000	–	–	0.09%	52
2023 Q3	$7.74M	Hold	2,000,000	–	–	0.04%	53
2023 Q2	$11.9M	Hold	2,000,000	–	–	0.07%	52
2023 Q1	$6.54M	Buy	+2,000,000	New	+$7.99M	0.04%	63

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Baker Bros. Advisors's SANA Position: Q2 2026 in Review

Baker Bros. Advisors held its Sana Biotechnology (SANA) position steady in Q2 2026 at 310,483 shares worth $1.08M. The position accounts for 0.01% of the portfolio, ranked #81.

Baker Bros. Advisors first reported a position in SANA in Q1 2023 and has held it in 14 quarters since. The position peaked at $23.8M in Q1 2024. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Baker Bros. Advisors held 310,483 shares of Sana Biotechnology worth $1.08M as of Q2 2026.
Baker Bros. Advisors left its Sana Biotechnology share count unchanged in Q2 2026.
Sana Biotechnology made up 0.01% of Baker Bros. Advisors's portfolio in Q2 2026, its #81 holding.
Baker Bros. Advisors first reported a position in Sana Biotechnology in Q1 2023 and has held it in 14 quarters since.
Baker Bros. Advisors's Sana Biotechnology position peaked at $23.8M in Q1 2024.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Baker Bros. Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.